CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease
Hee Young Ju, Hyoung Jin Kang, Che Ry Hong, Ji Won Lee, Hyery Kim, Sang Hoon Song, Kyung-Sang Yu, In-Jin Jang, June Dong Park, Kyung Duk Park, Hee Young Shin, Joong-Gon Kim, Hyo Seop Ahn
Clin Exp Pediatr. 2016;59(Suppl 1):S57-S59.   Published online November 30, 2016
DOI: https://doi.org/10.3345/kjp.2016.59.11.S57

Excel Download

Successful Half-Dose Busulfan/Full-Dose Fludarabine Based Reduced Intensity Conditioning In High-Risk Pediatric And Adult Chronic Granulomatous Disease (CGD) Patients
Biology of Blood and Marrow Transplantation. 2010;16(2):S181-S182   Crossref logo
Link1 Link2

A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease
Biology of Blood and Marrow Transplantation. 2016;22(11):2011-2018   Crossref logo
Link1 Link2

Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease
Korean Journal of Pediatrics. 2016;59(Suppl 1):S57   Crossref logo
Link1 Link2 Link3

Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning
Bone Marrow Transplantation. 2001;28(1):93-96   Crossref logo
Link1 Link2 Link3

Pretransplant conditioning with fludarabine and IV busulfan, reduced toxicity and increased safety without compromising antitumor efficacy and overall treatment effect?
Bone Marrow Transplantation. 2016;51(7):919-920   Crossref logo
Link1 Link2 Link3

Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation
International Journal of Hematology. 2007;87(1):88-90   Crossref logo
Link1 Link2 Link3

Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning
Bone Marrow Transplantation. 2014;49(9):1162-1169   Crossref logo
Link1 Link2 Link3

Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation
Bone Marrow Transplantation. 2006;38(7):477-482   Crossref logo
Link1 Link2 Link3

A Single Center Experience Using Alemtuzumab, Fludarabine, Melphalan and Thiotepa as Conditioning for Transplant in Chronic Granulomatous Disease
Biology of Blood and Marrow Transplantation. 2017;23(3):S227   Crossref logo
Link1 Link2

HLA-matched HSCT using targeted busulfan-based conditioning in children with primary hemophagocytic lymphohistiocytosis
Bone Marrow Transplantation. 2021;56(12):3097-3099   Crossref logo
Link1 Link2 Link3